NuVasive launches Reline 3D for paediatric spinal deformity

948
Reline 3D

NuVasive has today announced the expansion of its complex spine portfolio with the global commercial availability of Reline 3D, a posterior fixation system for patients suffering from paediatric spinal deformities.

The Reline 3D system is optimised for the treatment of adolescent idiopathic scoliosis (AIS), which involves intricate surgical techniques to address the three-dimensional deformity present in the spine. The system unifies current deformity techniques involving multi-step, single-plane correction, into one holistic procedure enabling surgeons to overcome current inefficiencies in the operating room, the company said in a press release. Reline 3D is designed to provide simultaneous, three-dimensional deformity correction, through a simplified procedure, offering surgeons versatility without sacrificing a reproducible surgical experience.

“Prior to Reline 3D, my approach to treating three-dimensional spinal deformities in pediatrics was inefficient and required treating the coronal, sagittal, and axial planes separately,” said Robert Cho, chief of staff and paediatric orthopaedic surgeon at Shriners for Children Medical Center in Pasadena, USA. “Reline 3D allows me to simultaneously correct all three planes of the deformity at once, minimising stress on the bone-screw interface and rod deformation, and maximising my three-dimensional correction in patients with complex spinal curvatures.”

Reline 3D is an extension of NuVasive’s Reline system, including Reline Open, Reline MAS, Reline Trauma and Reline Small Stature

“Reline 3D represents a true procedural solution that increases efficiencies and supports a less invasive approach to addressing complex pathologies,” said Matt Link, president of NuVasive. “As an innovative leader in less invasive surgery, NuVasive is committed to providing industry-leading procedures and technologies that enable health systems and surgeons to provide the same standard of care while reducing operative time and length of stay in the hospital. With this launch of Reline 3D, we have expanded this commitment to the AIS patient population.”

Reline 3D is commercially available to patients within the USA and European markets, and is expected to launch in other countries next year.

“As a key pioneer in expanding the utility of NuVasive’s Reline portfolio to create the Reline 3D system, it excites me that this differentiated solution is now widely available to the global spinal deformity community,” said Stewart Tucker, orthopaedic surgeon at Great Ormond Street Hospital in London, UK. “Reline 3D creates a streamlined solution for complex deformities and my peers in the European spinal community have converted to using it simply based on its correctional ability, efficiencies and versatile applications across paediatric and adult spinal deformities.”


LEAVE A REPLY

Please enter your comment!
Please enter your name here